Equitec Proprietary Markets, LLC Abb Vie Inc. Call Options Transaction History

Equitec Proprietary Markets, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 Apr 22, 2022	SELL	$131.98 - $163.75 $1.04 Million - $1.29 Million	-7,900 Closed	0 $0
Q2 2021 Jul 20, 2021	SELL	$105.21 - $117.21 $1.34 Million - $1.49 Million	-12,700 Reduced 61.65%	7,900 $890,000
Q4 2020 Jan 26, 2021	SELL	$80.49 - $108.67 $1.97 Million - $2.66 Million	-24,500 Reduced 54.32%	20,600 $2.21 Million
Q3 2020 Oct 13, 2020	BUY	$85.91 - $100.83 $3.2 Million - $3.75 Million	37,200 Added 470.89%	45,100 $3.95 Million
Q1 2020 Apr 19, 2021	BUY	$64.5 - $97.79 $509,550 - $772,541	7,900 New	7,900 $0

3,773

1.28B

13M

9.82M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $354B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Equitec Proprietary Markets, LLC, based on Form 13F filings with the SEC.

Stay updated on Equitec Proprietary Markets, LLC with notifications on news.